4.7 Article

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 3, Pages 633-640

Publisher

WILEY
DOI: 10.1002/ijc.26410

Keywords

effector phase inhibition; lactic acid; T cell receptor signaling; adoptive T cell therapy; cytotoxic T cells

Categories

Funding

  1. Deutsche Forschungsgemeinschaft [SFB-TR36, SFB455, DFG KR1418/7-1]

Ask authors/readers for more resources

Lactic acidosis is common to most solid tumors and has been found to affect infiltrating immune cells. Here we document effector phase inhibition of cytotoxic T cells (CTLs) involving complete blockage of cytokine production and partial impairment of lytic granule exocytosis. Lactic acidosis impaired TCR-triggered phosphorylation of JNK, c-Jun and p38, while not affecting MEK1 and ERK. The select targeting of signaling proteins involved in IFN? production (JNK/c-Jun, p38) without affecting those jointly used in cytokine regulation and granule exocytosis (MEK1/ERK) explains the observed split effect of lactic acidosis on the CTL responses. CTL inhibition by lactic acidosis showed fast dynamics with immediate onset and reversion. Functional recovery by neutralizing the extracellular pH despite continuous presence of lactate holds promise that CTL activity can be improved in the milieu of solid tumors with appropriate anti-acidosis treatment, thereby increasing the efficacy of adoptive T cell therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available